Found: 26
Select item for more details and to access through your institution.
The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 515, doi. 10.1007/s00280-013-2214-x
- By:
- Publication type:
- Article
Effects of β-lapachone, a new anticancer candidate, on cytochrome P450-mediated drug metabolism.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 493, doi. 10.1007/s00280-013-2220-z
- By:
- Publication type:
- Article
Compatibility of intravenous fosaprepitant with intravenous 5-HT antagonists and corticosteroids.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 509, doi. 10.1007/s00280-013-2201-2
- By:
- Publication type:
- Article
Effects of β-lapachone, a new anticancer candidate, on cytochrome P450-mediated drug metabolism.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 699, doi. 10.1007/s00280-013-2230-x
- By:
- Publication type:
- Article
Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 653, doi. 10.1007/s00280-013-2241-7
- By:
- Publication type:
- Article
Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 643, doi. 10.1007/s00280-013-2240-8
- By:
- Publication type:
- Article
Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 565, doi. 10.1007/s00280-013-2227-5
- By:
- Publication type:
- Article
CPT-11 as a second-line treatment for patients with advanced/metastatic gastric cancer who failed S-1 (CCOG0702).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 629, doi. 10.1007/s00280-013-2235-5
- By:
- Publication type:
- Article
The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 597, doi. 10.1007/s00280-013-2231-9
- By:
- Publication type:
- Article
Clinical effects of A4889G and T6235C polymorphisms in cytochrome P-450 CYP1A1 for breast cancer patients treated with tamoxifen: implications for tumor aggressiveness and patient survival.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 529, doi. 10.1007/s00280-013-2221-y
- By:
- Publication type:
- Article
The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 703, doi. 10.1007/s00280-013-2236-4
- By:
- Publication type:
- Article
A phase II study of intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 545, doi. 10.1007/s00280-013-2225-7
- By:
- Publication type:
- Article
A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 537, doi. 10.1007/s00280-013-2224-8
- By:
- Publication type:
- Article
Scheduling of paclitaxel and gefitinib to inhibit repopulation for optimal treatment of human cancer cells and xenografts that overexpress the epidermal growth factor receptor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 585, doi. 10.1007/s00280-013-2229-3
- By:
- Publication type:
- Article
Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 553, doi. 10.1007/s00280-013-2226-6
- By:
- Publication type:
- Article
Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 683, doi. 10.1007/s00280-013-2247-1
- By:
- Publication type:
- Article
The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 669, doi. 10.1007/s00280-013-2246-2
- By:
- Publication type:
- Article
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 619, doi. 10.1007/s00280-013-2234-6
- By:
- Publication type:
- Article
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 607, doi. 10.1007/s00280-013-2232-8
- By:
- Publication type:
- Article
Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 709, doi. 10.1007/s00280-013-2243-5
- By:
- Publication type:
- Article
A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 637, doi. 10.1007/s00280-013-2239-1
- By:
- Publication type:
- Article
Phase I and pharmacokinetic/pharmacodynamic study of RO5126766, a first-in-class dual Raf/MEK inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 577, doi. 10.1007/s00280-013-2228-4
- By:
- Publication type:
- Article
Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 661, doi. 10.1007/s00280-013-2242-6
- By:
- Publication type:
- Article